Document is current
Any future updates will be listed below
-
Authors
Choi, Seung Woo
Seo, Sooin
Hong, Hye Kyoung
Yoon, So Jung
Kim, Minah
Moon, Sunghyun
Lee, Joo Yong
Lim, Jaeseung
Lee, Jong Bum
Woo, Se Joon https://orcid.org/0000-0003-3692-7169
-
Funding
Funding for this research was provided by:
Seoul National University Bundang Hospital (14-2021-0001)
Seoul National University Bundang Hospital (18-2020-0006)
- License Information
-
More Information
Article History
Received: 11 April 2023
Revised: 12 May 2023
Accepted: 15 May 2023
First Online: 13 July 2023
Declarations
:
: SWC, SS, HKH, SJY, MK, SM, JYL, JBL, and SJW have no competing interest. JL is the founder and CEO of Cellatoz Therapeutics lnc.
: The protocols were approved by institutional review board of Ewha Womans University Mokdong Hospital (title of the approved project: Establishment of cell banks of human tonsil-derived stem cells and development of a cell therapy, IRB no. EUMC2021-09-036, date of approval: 2021-10-20). Informed consents were obtained from all patients. All animal experimental procedures were approved by the Seoul National University Bundang Hospital institutional animal care and use committee (title of the approved project: Investigation of regenerative treatment efficacy for the retinal degeneration using stem cell-derived extracellular vesicles, IACUC no. BA-2008-302-075-07, date of approval: 2020-08-21), and were conducted in accordance with the ARVO Statement for the use of animals in ophthalmic and vision research.
